Search

John B. Strege

Examiner (ID: 10245, Phone: (571)272-7457 , Office: P/2665 )

Most Active Art Unit
2665
Art Unit(s)
2669, 2625, 2624, 2665
Total Applications
1853
Issued Applications
1516
Pending Applications
147
Abandoned Applications
212
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
08/073526 RETROVIRUS-LIKE PARTICLES CONTAINING MODIFIED ENVELOPE GLYCOPROTEINS Jun 8, 1993 Pending
08/052727 METHOD OF PRODUCING ANTIBODIES TO ANTIGENS OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) Apr 26, 1993 Pending
Array ( [id] => 3487907 [patent_doc_number] => 05470720 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-28 [patent_title] => 'HIV antibody assays comprising p24-gp41 chimeric antigens' [patent_app_type] => 1 [patent_app_number] => 8/049531 [patent_app_country] => US [patent_app_date] => 1993-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15169 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/470/05470720.pdf [firstpage_image] =>[orig_patent_app_number] => 049531 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/049531 		HIV antibody assays comprising p24-gp41 chimeric antigens Apr 19, 1993 Issued
08/038356 LIVE, RECOMBINANT LISTERIA SPP. VACCINES AND PRODUCTION OF CYTOTOXIC T-CELL RESPONSE Mar 25, 1993 Pending
08/036218 GENETICALLY ENGINEERED VACCINE STRAIN Mar 23, 1993 Pending
Array ( [id] => 3070824 [patent_doc_number] => 05364773 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-15 [patent_title] => 'Genetically engineered vaccine strain' [patent_app_type] => 1 [patent_app_number] => 8/036217 [patent_app_country] => US [patent_app_date] => 1993-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8250 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/364/05364773.pdf [firstpage_image] =>[orig_patent_app_number] => 036217 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/036217 		Genetically engineered vaccine strain Mar 23, 1993 Issued
07/974589 VACCINES Feb 21, 1993 Abandoned
08/021622 RECOMBINANT RETROVIRUSES AND USES THEREOF Feb 16, 1993 Abandoned
08/015414 RECOMBINANT VIRAL PARTICLE VACCINES Feb 7, 1993 Abandoned
08/012243 IMMUNOLOGICALLY ACTIVE POLYPEPTIDES WITH ALTERED TOXICITY USEFUL FOR THE PREPARATION OF AND ANTIPERTUSSIS VACCINE Jan 31, 1993 Abandoned
08/011644 RECOMBINANT MUTANTS FOR INDUCING SPECIFIC IMMUNE RESPONSES Jan 28, 1993 Abandoned
08/008342 GENETIC IMMUNIZATION Jan 25, 1993 Abandoned
08/007115 RECOMBINANT VIRUS IMMUNOTHERAPY Jan 20, 1993 Abandoned
08/006252 HIV-1 ENVELOPE MUTEINS LACKING HYPERVARIABLE DOMAINS Jan 18, 1993 Abandoned
08/003233 COMPOSITIONS AND METHODS FOR INDUCING CYTOTOXIC T LYMPHOCYTE RESPONSES BY IMMUNIZATION WITH PROTEIN ANTIGENS Jan 10, 1993 Abandoned
Array ( [id] => 3409600 [patent_doc_number] => 05443828 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-22 [patent_title] => 'Chimeric HIV-2 gag particles' [patent_app_type] => 1 [patent_app_number] => 7/992618 [patent_app_country] => US [patent_app_date] => 1992-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 5329 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/443/05443828.pdf [firstpage_image] =>[orig_patent_app_number] => 992618 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/992618 		Chimeric HIV-2 gag particles Dec 17, 1992 Issued
07/987506 EXPRESSION VECTORS AND THEIR USE IN THE PREPARATION OF HIV-RESISTANT HUMAN CELLS FOR THERAPEUTIC APPLICATIONS Dec 6, 1992 Abandoned
07/979460 LIVE ATTENUATED MICROORGANISMS FOR VACCINE Nov 19, 1992 Abandoned
07/927489 HEPATITIS B VACCINE Nov 15, 1992 Abandoned
Array ( [id] => 3516785 [patent_doc_number] => 05506119 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-09 [patent_title] => 'DNA encoding variant CD44 surface proteins associated with metastatic tumors' [patent_app_type] => 1 [patent_app_number] => 7/946497 [patent_app_country] => US [patent_app_date] => 1992-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 6843 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 321 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/506/05506119.pdf [firstpage_image] =>[orig_patent_app_number] => 946497 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/946497 		DNA encoding variant CD44 surface proteins associated with metastatic tumors Nov 8, 1992 Issued
Menu